Vident Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Sell |
5,000
-738
| -13% | -$299K | 0.02% | 497 |
|
|
2025
Q1 | $2.86M | Buy |
5,738
+1,092
| +24% | +$543K | 0.04% | 366 |
|
|
2024
Q4 | $2.42M | Sell |
4,646
-11
| -0.2% | -$5.72K | 0.04% | 370 |
|
|
2024
Q3 | $2.88M | Buy |
4,657
+1,083
| +30% | +$670K | 0.07% | 298 |
|
|
2024
Q2 | $1.98M | Buy |
3,574
+408
| +13% | +$226K | 0.05% | 376 |
|
|
2024
Q1 | $1.84M | Buy |
3,166
+166
| +6% | +$96.5K | 0.04% | 392 |
|
|
2023
Q4 | $1.59M | Sell |
3,000
-86
| -3% | -$45.6K | 0.04% | 434 |
|
|
2023
Q3 | $1.56M | Buy |
+3,086
| New | +$1.56M | 0.05% | 377 |
|